Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Return on Sales (2020 - 2025)

Historic Return on Sales for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to 0.13%.

  • NeuroPace's Return on Sales rose 1400.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25%, marking a year-over-year increase of 1300.0%. This contributed to the annual value of 0.34% for FY2024, which is 1600.0% up from last year.
  • Latest data reveals that NeuroPace reported Return on Sales of 0.13% as of Q3 2025, which was up 1400.0% from 0.35% recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Return on Sales registered a high of 0.13% during Q3 2025, and its lowest value of 1.24% during Q2 2022.
  • Its 5-year average for Return on Sales is 0.58%, with a median of 0.5% in 2021.
  • As far as peak fluctuations go, NeuroPace's Return on Sales plummeted by -7300bps in 2022, and later soared by 6800bps in 2023.
  • Over the past 5 years, NeuroPace's Return on Sales (Quarter) stood at 0.97% in 2021, then grew by 12bps to 0.86% in 2022, then soared by 58bps to 0.36% in 2023, then skyrocketed by 33bps to 0.24% in 2024, then surged by 46bps to 0.13% in 2025.
  • Its Return on Sales stands at 0.13% for Q3 2025, versus 0.35% for Q2 2025 and 0.29% for Q1 2025.